Analysis of Investigational Drugs in Biological Fluids - Method Development and Routine Assay
Abstract
Work on development and/or validation of analytical methodologies during the first half of the contract focused on assays for WR 238,605, halofantrine (and its metabolite), WR 6026 (and its metabolites), mefloquine (and its metabolite), artelinic acid, p-aminoheptanophenone (and related compounds), and primaquine (and its metabolite). Work on routine analyses of biological specimens during this period was performed for studies that required determination of concentrations of WR 238,605, halofantrine (and its metabolite) , WR 6026 (and its metabolites), mefloquine (and its metabolite), p- aminoheptanophenone (and related compounds), and primaquine (and its metabolite) . HPLC, Plasma, Blood, WR 238,605, Halofantrine, WR 6026, Mefloquine, Artelinic acid, p-aminoheptanophenone, Primaquine, Assay
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 14, 1994
- Accession Number
- ADA284637
Entities
People
- Emil T. Lin
Organizations
- University of California, San Francisco